ArticleJournal of Crohn's & colitis2019

GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD.

Tim Dierckx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.